Tuberculosis and aging: A global health problem

Clinical Infectious Diseases

Volumn 33, Issue 7, 2001, Pages 1034-1039

  Rajagopalan, S ^a  

^a KING DREW MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADVERSE DRUG REACTION; AGE; AGED; AGING; ARTICLE; CLINICAL FEATURE; COMORBIDITY; DIFFERENTIAL DIAGNOSIS; EPIDEMIC; HUMAN; IMMUNE STATUS; INFECTION SENSITIVITY; INSTITUTIONALIZATION; MORBIDITY; MORTALITY; PRIORITY JOURNAL; SYMPTOM; TUBERCULOSIS; TUBERCULOSIS CONTROL; WORLD HEALTH ORGANIZATION;

AGED; AGING; ANTITUBERCULAR AGENTS; HUMANS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; WORLD HEALTH;

EID: 0035478744     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/322671     Document Type: Article

References (35)

1. Tuberculosis in the elderly: An international perspective
2. Tuberculosis in aging adults
3. Tuberculosis elimination revisited: Obstacles, opportunities and a renewed commitment
4. Long-term risk of tuberculosis among foreign-born persons in the United States
5. Special problems in tuberculosis: Tuberculosis in the elderly and in residential homes, correctional facilities, long-term care hospitals, mental hospitals, shelters for the homeless, and jails
6. Tuberculosis as an endemic and nosocomial infection among the elderly in nursing homes
7. Pathogenesis of tuberculosis: Native and acquired resistance in animals and humans
8. Studies on the mechanism of immunity in tuberculosis: The fate of tubercle bacilli ingested by mononuclear phagocytes derived from normal and immunized animals
9. Anergy in active pulmonary tuberculosis: A comparison between positive and negative reactors and an evaluation of 5 TU and 250 skin test doses
10. Tuberculosis in the geriatric patient
11. The challenge and unique aspects of tuberculosis in older patients
12. Does aging modify pulmonary tuberculosis? A meta analytical review
13. Tuberculosis in the elderly
14. Miliary tuberculosis
15. Tuberculous meningitis
16. The changed pattern of bone and joint tuberculosis in Norway
17. Results of treatment of spinal tuberculosis by "middle-path" regime
18. Tuberculosis of peripheral joints: An often missed diagnosis
19. Genitourinary tuberculosis: A study of 1117 cases over a period of 34 years
20. The booster phenomenon in serial tuberculin testing
21. Booster effect in elderly patients living in geriatric institutions
22. Flexible bmnchoscopy as a diagnostic tool in the evaluation of pulmonary tuberculosis in an elderly population
23. Diagnostic standards and classification of tuberculosis in adults and children
24. Clinical diagnostic value of the PCR assay for detection of Mycobacterium tuberculosis
25. Nucleic acid amplification tests for tuberculosis
26. Treatment and prevention of tuberculosis in adults and children
27. Toxic effects of isoniazid in tuberculosis chemoprophylaxis: Role of biochemical monitoring in 1000 patients
28. Targeted skin testing and treatment of latent tuberculosis infection
29. How much isoniazid is needed for prophylaxis?
30. How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?
31. Prevention control of tuberculosis in facilities providing long-term care to the elderly: Recommendations of the Advisory Committee for Elimination of Tuberculosis
32. Tuberculosis in long-term care facilities
33. An overview of the proceedings of the International Symposium on Tuberculosis Vaccine Development and Evaluation: recognizing and addressing the barriers